In cancer cells BRD4 inhibition suppresses super-enhancer and IFN-γ driven transcription of PD-L1 (CD274 gene) by preventing binding of BRD4 and IRF1 to its promoter and enhancer regions [174,175,176,177,178]. Here, BRD4 is linked to cancer.